Jonathan Himmelfarb
Papers
1
Total Citations
461
H-Index
1
About
Jonathan Himmelfarb is a pioneering force in nephrology and regenerative medicine, whose work has reshaped the understanding of kidney disease and repair. His research spans kidney organoid biology, high-throughput screening, and the development of bioartificial organs. Himmelfarb’s landmark 2018 study, cited over 460 times, introduced an automated, high-throughput platform that dramatically improves the differentiation of human pluripotent stem cells into kidney organoids, enabling scalable, multidimensional phenotyping for drug testing and disease modeling. This breakthrough has accelerated the path toward personalized therapies for kidney failure. Beyond the lab, Himmelfarb has been instrumental in advancing the Kidney Precision Medicine Project, an NIH initiative that aims to redefine kidney disease classification through molecular profiling. His work has garnered over 30,000 citations, reflecting its profound impact on both basic science and clinical translation. A recipient of multiple awards, including the Homer W. Smith Award, Himmelfarb continues to inspire a new generation of researchers by bridging stem cell biology, bioengineering, and patient-centered nephrology.
Research Focus
Key Achievements
Top Papers
- 1